Skip to main content

Search results for "pharmaceutical company"

Filters: 2012 2012 ×
Viewing 1 - 17 of 17 results by relevance

Roundtable on Translating Genomic-Based Research for Health: 2012 Annual Report  (2013)

Consensus Study Report

A Review of the Manufacturing-Related Programs at the National Institute of Standards and Technology: Fiscal Year 2012  (2012)

Proceedings

Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary  (2012)

Proceedings

Research Frontiers in Bioinspired Energy: Molecular-Level Learning from Natural Systems: Report of a Workshop  (2012)

Proceedings

Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary  (2012)

Proceedings

Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary  (2012)

Consensus Study Report

Ranking Vaccines: A Prioritization Framework: Phase I: Demonstration of Concept and a Software Blueprint  (2012)

Proceedings

The Role of the Chemical Sciences in Finding Alternatives to Critical Resources: A Workshop Summary  (2012)

Proceedings

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary  (2012)

The Ramifications of Post-Kelo Legislation on State Transportation Projects  (2012)

Consensus Study Report

Rising to the Challenge: U.S. Innovation Policy for the Global Economy  (2012)

Proceedings

Clustering for 21st Century Prosperity: Summary of a Symposium  (2012)

Proceedings

Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary  (2012)

Proceedings

Perspectives on Essential Health Benefits: Workshop Report  (2012)

Consensus Study Report

Epilepsy Across the Spectrum: Promoting Health and Understanding  (2012)

Consensus Study Report

Scientific Standards for Studies on Modified Risk Tobacco Products  (2012)

Consensus Study Report

Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act  (2012)